CVRx (CVRX) Competitors $12.35 -0.61 (-4.71%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$12.56 +0.21 (+1.67%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CVRX vs. CDRE, LQDA, INMD, BLFS, RXST, AORT, MDXG, PLSE, FNA, and ESTAShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Cadre (CDRE), Liquidia (LQDA), InMode (INMD), BioLife Solutions (BLFS), RxSight (RXST), Artivion (AORT), MiMedx Group (MDXG), Pulse Biosciences (PLSE), Paragon 28 (FNA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. CVRx vs. Cadre Liquidia InMode BioLife Solutions RxSight Artivion MiMedx Group Pulse Biosciences Paragon 28 Establishment Labs CVRx (NASDAQ:CVRX) and Cadre (NYSE:CDRE) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability. Is CVRX or CDRE more profitable? Cadre has a net margin of 6.34% compared to CVRx's net margin of -116.91%. Cadre's return on equity of 12.88% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-116.91% -93.06% -51.78% Cadre 6.34%12.88%6.06% Which has higher valuation and earnings, CVRX or CDRE? Cadre has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M6.27-$59.97M-$2.69-4.59Cadre$516.16M2.55$38.64M$0.8339.06 Which has more risk and volatility, CVRX or CDRE? CVRx has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Do analysts recommend CVRX or CDRE? CVRx presently has a consensus target price of $17.83, suggesting a potential upside of 44.40%. Cadre has a consensus target price of $39.67, suggesting a potential upside of 22.35%. Given CVRx's stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than Cadre.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Cadre 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Do insiders and institutionals hold more shares of CVRX or CDRE? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 18.9% of CVRx shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community prefer CVRX or CDRE? CVRx received 17 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 73.33% of users gave CVRx an outperform vote while only 55.17% of users gave Cadre an outperform vote. CompanyUnderperformOutperformCVRxOutperform Votes3373.33% Underperform Votes1226.67% CadreOutperform Votes1655.17% Underperform Votes1344.83% Does the media refer more to CVRX or CDRE? In the previous week, CVRx had 1 more articles in the media than Cadre. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Cadre. CVRx's average media sentiment score of 0.97 beat Cadre's score of 0.00 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cadre 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCVRx beats Cadre on 10 of the 18 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$321.55M$4.58B$5.81B$8.43BDividend YieldN/A36.92%4.76%3.97%P/E Ratio-4.5930.3924.9319.24Price / Sales6.2750.34375.35110.20Price / CashN/A51.0838.0534.58Price / Book4.526.267.374.28Net Income-$59.97M$67.64M$3.18B$247.04M7 Day Performance-6.58%-5.18%-2.92%-3.26%1 Month Performance-24.00%-9.68%-6.83%-6.57%1 Year Performance-38.25%10.60%12.61%4.01% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.366 of 5 stars$12.35-4.7%$17.83+44.4%-40.6%$321.55M$51.29M-4.59160CDRECadre2.3169 of 5 stars$33.34-0.7%$39.67+19.0%-9.3%$1.35B$482.53M40.172,435Upcoming EarningsLQDALiquidia2.9688 of 5 stars$15.89-1.4%$25.38+59.7%+2.4%$1.34B$15.61M-9.7550INMDInMode2.0046 of 5 stars$19.12+1.2%$22.25+16.4%-17.6%$1.33B$394.82M8.14480Positive NewsBLFSBioLife Solutions1.4845 of 5 stars$25.72-3.6%$29.43+14.4%+36.4%$1.19B$146.96M-24.26440Earnings ReportNews CoveragePositive NewsRXSTRxSight3.5368 of 5 stars$29.29-1.0%$58.13+98.4%-51.7%$1.18B$89.08M-35.29220Earnings ReportAORTArtivion1.8341 of 5 stars$27.90-1.3%$31.80+14.0%+32.2%$1.17B$354M-1,394.901,500High Trading VolumeMDXGMiMedx Group3.2735 of 5 stars$7.95-0.4%$12.00+50.9%-3.8%$1.17B$321.48M14.45870Earnings ReportAnalyst RevisionPLSEPulse Biosciences1.4094 of 5 stars$18.76-3.6%N/A+74.0%$1.15B$700,000.000.00140FNAParagon 281.5605 of 5 stars$13.06+0.3%$14.20+8.8%+10.7%$1.09B$216.39M-17.64343,000Upcoming EarningsShort Interest ↓ESTAEstablishment Labs2.0321 of 5 stars$35.21+5.3%$60.60+72.1%-2.8%$985.88M$165.15M-13.65960Earnings Report Related Companies and Tools Related Companies CDRE Competitors LQDA Competitors INMD Competitors BLFS Competitors RXST Competitors AORT Competitors MDXG Competitors PLSE Competitors FNA Competitors ESTA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CVRX) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.